drugset / Trial / NCT03838575
ROSSINI 2 - Reduction of Surgical Site Infection Using Several Novel Interventions
Phase 3
Unknown
6610 enrolled
University of Birmingham
National Institute for Health Research, United Kingdom · collabUniversity College, London · collab
RandomizedParallel-groupDouble-blindPrevention
Summary
ROSSINI 2 is a phase III, multi-arm, multi-stage (MAMS) pragmatic, blinded (patient and outcome assessor), multicentre, randomised controlled trial (RCT) with an internal pilot, to evaluate the use of several in-theatre interventions, used alone or in combination, to reduce SSI rates in patients undergoing surgery.
Timeline
- Start
- 2019-03-01
- Primary completion
- 2023-05
- Completion
- 2023-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Chlorhexidine | Small molecule | 2 % | Topical |
Indications
No indication recorded.